GKN3P: A Drug Target / Disease Biomarker (G100132413)

Target Name: GKN3P

NCBI ID: G100132413

GKN3P

Other Name(s): gastrokine 3, pseudogene | Gastrokine 3, pseudogene

GKN3P: A Drug Target / Disease Biomarker

GKN3P, also known as GLT-1, is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and muscle. It is a member of the GLT family, which includes several other proteins that play important roles in cellular signaling. One of the unique features of GKN3P is its ability to interact with several different signaling pathways, including the TGF-β pathway and the Wnt pathway. This makes it an attractive target for researchers to study and potentially develop as a drug.

GKN3P has been shown to play a role in several different processes in the body. For example, it has been shown to be involved in the development and maintenance of cancer cells. Studies have shown that GKN3P can promote the growth and survival of cancer cells, and that it is often expressed at higher levels in cancer cells compared to healthy cells. This suggests that targeting GKN3P may be an effective way to treat cancer.

Another role for GKN3P is in the regulation of pancreatic function. GKN3P has been shown to play a role in the development and maintenance of pancreatic ductal adenocarcinoma, which is a type of pancreatic cancer. Studies have shown that GKN3P can promote the growth and survival of pancreatic cancer cells, and that it is often expressed at higher levels in pancreatic cancer cells compared to healthy cells. This suggests that targeting GKN3P may be an effective way to treat pancreatic cancer.

In addition to its role in cancer and pancreatic function, GKN3P is also involved in the regulation of cellular signaling pathways. For example, GKN3P has been shown to play a role in the Wnt pathway, which is a signaling pathway that is involved in the development and maintenance of many different tissues in the body. Studies have shown that GKN3P can interact with the Wnt signaling pathway, and that this interaction may be involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

GKN3P has also been shown to play a role in the regulation of the TGF-β pathway, which is a signaling pathway that is involved in the development and maintenance of many different tissues in the body. Studies have shown that GKN3P can interact with the TGF-β pathway, and that this interaction may be involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

In conclusion, GKN3P is a protein that is expressed in various tissues throughout the body, and it is involved in several different processes in the body. Its ability to interact with several different signaling pathways makes it an attractive target for researchers to study and potentially develop as a drug. Further research is needed to fully understand the role of GKN3P in the regulation of cellular processes, and to determine the most effective way to target it.

Protein Name: Gastrokine 3, Pseudogene

Functions: May inhibit gastric epithelial cell proliferation

The "GKN3P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GKN3P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets